Abstract
Pentachlorophenol (PCP) was given orally to three volunteers at single doses of 3.9, 4.5, 9, and 18.8 mg. Daily urinary excretion of PCP and PCP conjugated to glucuronic acid was monitored using gas chromatography with electron capture detection (GC/ECD). Based on first-order elimination kinetics an elimination half-life of 20 days was derived.
To eliminate interference by the uncontrolled absorption of PCP from the environment 0.98 mg 13C-PCP was taken by one of the volunteers. PCP levels in urine and plasma were determined using mass spectrometry (GC/ MS) with negative chemical ionization. An elimination half-life of 17 days was found in both urine and blood. The collected data were used to calculate the clearance of PCP: a value of 0.07 ml/min was found. The long elimination half-life of PCP is explained by the low urinary clearance due to the high plasma protein binding (>96%) and the tubular reabsorption. The pH-dependency of the elimination of PCP was investigated, and a distinct increase in the daily excretion was observed following alkalinization by oral administration of sodium bicarbonate.
In order to elucidate the role of the enterohepatic circulation as a possible pool for PCP in humans, the bile of cholelithiasis patients with postoperative T-drainage was investigated for PCP and compared with the corresponding urine and plasma levels, but no accumulation of PCP in the enterohepatic circulation could be observed.
The daily elimination and plasma levels of PCP in a group of individuals without a specific exposition were found to range from 10 to 48 μg/day and 19 to 36 μg/l, respectively.
Similar content being viewed by others
References
Ahlborg UG, Lindgren JE, Mercier M (1974) Metabolism of pentachlorophenol. Arch Toxicol 32: 271–281
Begley J, Reichert EL, Rashad MN, Klemmer HW (1977) Association between renal function tests and pentachlorophenol exposure. Clin Toxicol 11: 97–106
Bevenue A, Haley TJ, Klemmer HW (1967a) A note on the effects of a temporary exposure of an individual to pentachlorophenol. Bull Environ Contam Toxicol 2: 293–296
Bevenue A, Wilson J, Casarett LJ, Klemmer HW (1967b) A survey of pentachlorophenol content in human urine. Bull Environ Contam Toxicol 2: 319–332
Blatt WF, Robinson SM, Bixler HJ (1968) Membrane ultrafiltration: the ultrafiltration technique and its application to microsolute exchange and binding phenomena. Anal Biochem 26: 151–173
Bomhard A, Schaller HK, Triebig G (1984) Capillar-Gas-Chromatographie mit ECD- und MS-Detektion zur quantitativen Bestimmung von Pentachlorphenol im menschlichen Plasma und Harn. Z Anal Chem 319: 516–519
Braun WH, Sauerhoff MW (1976) The pharmacokinetic profile of pentachlorophenol in monkeys. Toxicol Appl Pharmacol 38: 525–533
Braun WH, Young JD, Blau GE, Gehrig PJ (1977) The pharmacokientics and metabolism of pentachlorophenol in rats. Toxicol Appl Pharmacol 41: 395–406
Braun WH, Blau GE, Chenoweth MB (1979) The metabolism/ pharmacokinetics of pentachlorophenol in man, and a comparison with the rat and monkey. Dev Toxicol Environ Sci 4: 289–296
Casarett LJ, Bevenue A, Yauger WL Jr, Whalen SA (1969) Observations on pentachlorophenol in human blood and urine. Am Ind Hyg Assoc J 30: 360–366
Dougherty RC (1978) Human exposure to pentachlorophenol. In: Rao KR (ed) Pentachlorophenol chemistry, pharmacology, and environmental toxicology, Environmental Science Research 12, Plenum Press, New York p 355
Edgerton TR, Moseman RF, Linder RE, Wright LH (1979) Multiresidue method for the determination of chlorinated phenol metabolites in urine. J Chromatogr 170: 331–342
Jakobson J, Yllner S (1971) Metabolism of 14C-pentachlorophenol in the mouse. Acta Pharmacol Toxicol 29: 513–524
Kalman DA (1984) Determination of pentachlorophenol and 2,3,4,6-tetrachlorophenol in human urine by high resolution gas chromatography. J Chromatogr Sci 22: 452–455
Koss G, Koransky W, Steinbach K (1976) Studies on the toxicology of hexachlorobenzene. II. Identification and determination of metabolites. Arch Toxicol 35: 107–114
Nilsson CA, Norström A, Andersson K, Rappe C (1978) Impurities in commercial products related to pentachlorophenol. In: Rao KR (ed) Pentachlorophenol chemistry, pharmacology and environmental toxicology Environmental Science Research 12, Plenum Press, New York p 313
Pearson JE, Shultz CD, Rivers JE, Gonzalez FM (1976) Pesticide levels of patients on chronic hemodialysis. Bull Environ Contam Toxicol 16: 556–558
Richterich R, Colombo JP (1978) Karger S (ed), Klinische Chemie, Theorie, Praxis, Interpretationen, 4th ed, Basel, p 541–562
Schlenk H, Gellermann IL (1960) Esterification of fatty acids with diazomethane on a small scale. Anal Chem 32: 1412–1414
Shafik TM (1973) The determination of pentachlorophenol and hexachlorophene in human adipose tissue. Bull Environ Contam Toxicol 10: 57–63
Zimmerli B, Marschall T, Marek B (1979) Orientierende Untersuchung zum Vorkommen von Pentachlorphenol im Humanurin. Mitt Gebiete Lebensm Hyg 70: 443–450
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Uhl, S., Schmid, P. & Schlatter, C. Pharmacokinetics of pentachlorophenol in man. Arch Toxicol 58, 182–186 (1986). https://doi.org/10.1007/BF00340979
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00340979